Press Releases

DUBLIN, Jan. 31, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it will release fourth quarter and full year 2019 financial results on Monday, February 10, 2020, prior to the open of U.S. financial markets.

LEXINGTON, Mass., Jan. 31, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a lea

NORTH CHICAGO, Ill., Jan. 31, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a change to the marketing authorization for MAVIRET® (glecaprevir/pibrentasvir) to shorten once-d

CHICAGO, Jan. 31, 2020 /PRNewswire/ -- The American College of Prosthodontists (ACP) welcomes Lars Bouma, DDS, MS, FACP, as the organization's new vice president. Dr. Bouma was sworn in for his one-year term at the 49th Annual Session of the ACP held in Miami, Oct. 30

WALTHAM, Mass., Jan. 31, 2020 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it has entered into an agreement with five leading life sciences investors, including Biotechnology Value Fund, L.P., Boxer

NORTH CHICAGO, Ill., Jan. 31, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for VENCLYXTO® (venetoclax) in combination with obinutuzumab for the treatm

WESTBROOK, Maine, Jan. 31, 2020 /PRNewswire/ -- Achieves revenue growth in Q4 of 10% on a reported and organic basis, driven by CAG Diagnostics recurring revenue reported and organic growth of 11% Reports 19% year-over-year increase in Catalyst placements at new and competitive accounts in Q4, supporting full year g

INDIANAPOLIS, Jan. 31, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Lilly's new mealtime insulin for the treatment of adults with diabetes as part of a multiple daily injection regimen or delivered by an insuli

DETROIT, Jan. 31, 2020 /PRNewswire/ -- The teen who had a double lung transplant after a vaping-related injury is sharing his story in hopes to inspire others – particularly teens – to stop vaping and seek alternatives for a healthier and happier life.

MENLO PARK, Calif., Jan. 30, 2020 /PRNewswire/ -- HALO Dx, Inc., a rapid growth technology company headquartered in Silicon Valley, has brought together top technology experts with leading radiologists to set the new standard of care for the industry. By leveraging leading-edge artificial intelligence, mobile and SaaS technology as well as the latest in genomics-ba